Several preclinical studies have explored the effects of NOTCH1 inhibition in CLL models, showing promising results in terms of suppressing CLL cell proliferation and inducing apoptosis [16, 17]. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.